enVVeno Medical press release (NVNO): Q3 GAAP EPS of -$6.29 misses by $3.94. As of September 30, 2026, enVVeno had cash and investments of approximately $18.5 m
CryptoAlerta — análise de criptomoedas e mercado em tempo real